The human cancer genome project--one more misstep in the war on cancer (Q34416425)

2 August 2017

The human cancer genome project--one more misstep in the war on cancer (English)

1 reference

2 August 2017

George L Gabor Miklos

series ordinal

1

1 reference

2 August 2017

1 May 2005

1 reference

2 August 2017

1 reference

2 August 2017

23

1 reference

2 August 2017

5

1 reference

2 August 2017

535-537

1 reference

https://scigraph.springernature.com/pub.10.1038/nbt0505-535

2 August 2017

0 references

cites work

The systemic progression of human cancer: a focus on the individual disseminated cancer cell--the unit of selection

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Cancer genes and the pathways they control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Somatic mutation theory of carcinogenesis: why it should be dropped and replaced.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Tumour suppression: putting on the brakes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Medicine. Why a new cancer drug works well, in some patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Neoadjuvant trastuzumab induces apoptosis in primary breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

High frequency of mutations of the PIK3CA gene in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Inactivation of hCDC4 can cause chromosomal instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Weakening link to colorectal cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Creation of human tumour cells with defined genetic elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Origin of multidrug resistance in cells with and without multidrug resistance genes: chromosome reassortments catalyzed by aneuploidy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Therapeutic implications of cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

21 January 2018

Cancer without disease.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Discordance between K-ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Genetic background is an important determinant of metastatic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Breast cancer stem cells revealed

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Epigenetics in human disease and prospects for epigenetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

How diagnosis with microarrays can help cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

inferred from DOI database lookup

7 January 2021

based on heuristic

Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population

1 reference

https://api.crossref.org/works/10.1038%2FNBT0505-535

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NBT0505-535

1 reference

2 August 2017

1 reference

PubMed ID

15877064